[HTML][HTML] Preclinical safety evaluation of chimeric antigen receptor-modified T cells against CD19 in NSG mice
H Wen, Z Qu, Y Yan, C Pu, C Wang… - Annals of …, 2019 - ncbi.nlm.nih.gov
Background With the increase of chimeric antigen receptor-modified T (CAR-T) cell therapy,
serious complications initiated by CAR-T cells have garnered wide attention. We have …
serious complications initiated by CAR-T cells have garnered wide attention. We have …
[PDF][PDF] Preclinical safety evaluation of chimeric antigen receptor-modified T cells against CD19 in NSG mice
H Wen, Z Qu, Y Yan, C Pu, C Wang, H Jiang, T Hou… - 2019 - cdn.amegroups.cn
Background: With the increase of chimeric antigen receptor-modified T (CAR-T) cell therapy,
serious complications initiated by CAR-T cells have garnered wide attention. We have …
serious complications initiated by CAR-T cells have garnered wide attention. We have …
Preclinical safety evaluation of chimeric antigen receptor-modified T cells against CD19 in NSG mice
H Wen, Z Qu, Y Yan, C Pu, C Wang… - Annals of …, 2019 - pubmed.ncbi.nlm.nih.gov
Background With the increase of chimeric antigen receptor-modified T (CAR-T) cell therapy,
serious complications initiated by CAR-T cells have garnered wide attention. We have …
serious complications initiated by CAR-T cells have garnered wide attention. We have …
Preclinical safety evaluation of chimeric antigen receptor-modified T cells against CD19 in NSG mice.
H Wen, Z Qu, Y Yan, C Pu, C Wang… - Annals of …, 2019 - europepmc.org
Background With the increase of chimeric antigen receptor-modified T (CAR-T) cell therapy,
serious complications initiated by CAR-T cells have garnered wide attention. We have …
serious complications initiated by CAR-T cells have garnered wide attention. We have …
[PDF][PDF] Preclinical safety evaluation of chimeric antigen receptor-modified T cells against CD19 in NSG mice
H Wen, Z Qu, Y Yan, C Pu, C Wang, H Jiang, T Hou… - 2019 - researchgate.net
Background: With the increase of chimeric antigen receptor-modified T (CAR-T) cell therapy,
serious complications initiated by CAR-T cells have garnered wide attention. We have …
serious complications initiated by CAR-T cells have garnered wide attention. We have …
[HTML][HTML] Preclinical safety evaluation of chimeric antigen receptor-modified T cells against CD19 in NSG mice
H Wen, Z Qu, Y Yan, C Pu, C Wang… - Annals of …, 2019 - atm.amegroups.org
Background: With the increase of chimeric antigen receptor-modified T (CAR-T) cell therapy,
serious complications initiated by CAR-T cells have garnered wide attention. We have …
serious complications initiated by CAR-T cells have garnered wide attention. We have …
Preclinical safety evaluation of chimeric antigen receptor-modified T cells against CD19 in NSG mice
H Wen, Z Qu, Y Yan, C Pu, C Wang… - Annals of …, 2019 - atm.amegroups.org
Background: With the increase of chimeric antigen receptor-modified T (CAR-T) cell therapy,
serious complications initiated by CAR-T cells have garnered wide attention. We have …
serious complications initiated by CAR-T cells have garnered wide attention. We have …
Preclinical safety evaluation of chimeric antigen receptor-modified T cells against CD19 in NSG mice.
H Wen, Z Qu, Y Yan, C Pu, C Wang… - Annals of …, 2019 - europepmc.org
Background With the increase of chimeric antigen receptor-modified T (CAR-T) cell therapy,
serious complications initiated by CAR-T cells have garnered wide attention. We have …
serious complications initiated by CAR-T cells have garnered wide attention. We have …